No abstract available
MeSH terms
-
Adalimumab
-
Antibodies, Monoclonal / therapeutic use
-
Antibodies, Monoclonal, Humanized / therapeutic use
-
Antirheumatic Agents / therapeutic use*
-
Disease Progression
-
Double-Blind Method
-
Humans
-
Infliximab
-
Multicenter Studies as Topic
-
Practice Guidelines as Topic
-
Randomized Controlled Trials as Topic
-
Spondylarthritis / classification
-
Spondylarthritis / drug therapy*
-
Treatment Outcome
-
Tumor Necrosis Factor-alpha / antagonists & inhibitors*
Substances
-
Antibodies, Monoclonal
-
Antibodies, Monoclonal, Humanized
-
Antirheumatic Agents
-
Tumor Necrosis Factor-alpha
-
Infliximab
-
Adalimumab